Sujal M. Patel - 05 Mar 2024 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CEO, President, and Secretary, Director, 10%+ Owner
Signature
/s/ Mathew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
05 Mar 2024
Net transactions value
+$99,054
Form type
4
Filing time
07 Mar 2024, 19:06:49 UTC
Previous filing
05 Mar 2024
Next filing
11 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $19,597 +7,405 +0.07% $2.65 10,021,893 05 Mar 2024 Direct F1
transaction NAUT Common Stock Purchase $25,034 +9,267 +0.09% $2.70 10,031,160 06 Mar 2024 Direct F2
transaction NAUT Common Stock Purchase $54,424 +18,854 +0.19% $2.89 10,050,014 07 Mar 2024 Direct F3
holding NAUT Common Stock 1,814,035 05 Mar 2024 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F4
holding NAUT Common Stock 5,280,476 05 Mar 2024 By PFV I, LLC F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 7,405 shares purchased in the price range of $2.58 to $2.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 9,267 shares purchased in the price range of $2.64 to $2.77 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average share price of an aggregate total of 18,854 shares purchased in the price range of $2.72 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F4 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
F5 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.